Mycoplasma pneumoniae: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
==Background==
==Background==
*Typically under 40 yrs
*Typically affects patients <40yo
*When causing pneumonia, this is also associated with bullous myringitis
*Causes:
**CAP
**Pneumonia
**[[Bullous myringitis]] - inflammation of the eardrum
**[[Bullous myringitis]] - painful, fluid filled vesicles on eardrum
***Painful, fluid filled vesicles  
***Presence of otalgia should prompt evaluation
***Presence of otalgia should prompt evaluation
***Streptococcus pneumoniae is also associated w/ bullous myringitis
***(Streptococcus pneumoniae is also associated w/ bullous myringitis)


==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==

Revision as of 04:25, 8 September 2015

Background

  • Typically affects patients <40yo
  • Causes:
    • Pneumonia
    • Bullous myringitis - painful, fluid filled vesicles on eardrum
      • Presence of otalgia should prompt evaluation
      • (Streptococcus pneumoniae is also associated w/ bullous myringitis)

Antibiotic Sensitivities[1]

Category Antibiotic Sensitivity
Penicillins Penicillin G R
Penicillin V R
Anti-Staphylocccal Penicillins Methicillin R
Nafcillin/Oxacillin R
Cloxacillin/Diclox. R
Amino-Penicillins AMP/Amox R
Amox-Clav R
AMP-Sulb R
Anti-Pseudomonal Penicillins Ticarcillin R
Ticar-Clav R
Pip-Tazo R
Piperacillin R
Carbapenems Doripenem R
Ertapenem R
Imipenem R
Meropenem R
Aztreonam R
Fluroquinolones Ciprofloxacin S
Ofloxacin S
Pefloxacin S
Levofloxacin S
Moxifloxacin S
Gemifloxacin S
Gatifloxacin S
1st G Cephalo Cefazolin X1
2nd G. Cephalo Cefotetan X1
Cefoxitin X1
Cefuroxime X1
3rd/4th G. Cephalo Cefotaxime X1
Cefizoxime X1
CefTRIAXone X1
Ceftaroline X1
CefTAZidime X1
Cefepime X1
Oral 1st G. Cephalo Cefadroxil X1
Cephalexin X1
Oral 2nd G. Cephalo Cefaclor/Loracarbef X1
Cefproxil X1
Cefuroxime axetil X1
Oral 3rd G. Cephalo Cefixime X1
Ceftibuten X1
Cefpodox/Cefdinir/Cefditoren X1
Aminoglycosides Gentamicin R
Tobramycin R
Amikacin R
Chloramphenicol S
Clindamycin R
Macrolides Erythromycin S
Azithromycin S
Clarithromycin S
Ketolide Telithromycin S
Tetracyclines Doxycycline S
Minocycline S
Glycylcycline Tigecycline S
Daptomycin X1
Glyco/Lipoclycopeptides Vancomycin X1
Teicoplanin X1
Telavancin X1
Fusidic Acid R
Trimethoprim X1
TMP-SMX X1
Urinary Agents Nitrofurantoin X1
Fosfomycin X1
Other Rifampin X1
Metronidazole R
Quinupristin dalfoppristin S
Linezolid R
Colistimethate X1

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

Table Overview

See Also

References

  1. Sanford Guide to Antimicrobial Therapy 2014